ReviewCurrent medicinal chemistry2025
Effect of Biomedical Hydrogels on Exercise-induced Muscle Damage: A Narrative Review.
Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Microalgae and exercise: from molecular mechanisms and brain health to clinical perspectives in the context of 3P medicine.The EPMA journal · 2025Review
- Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation.Archives of pharmacal research · 2025Review
- Combining exercise and nanoparticle-based therapies: a review of physiological synergies and pharmacological potential.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exercise-induced muscle damage (EIMD) is a common occurrence among athletes and individuals engaged in physical fitness activities. Muscle strains result from excessive or repetitive muscle tension, leading to tissue damage, inflammation, and pain. These strains can range from mild discomfort to severe damage, resulting in pain, inflammation, and reduced functionality. Effective management of muscle damage is crucial for promoting recovery and returning individuals to their desired level of activity. Conventional treatment modalities such as rest, ice, compression, and elevation (RICE), physical therapy, and nonsteroidal anti-inflammatory drugs (NSAIDs) have limitations in terms of efficacy and long-term outcomes. Consequently, there is a need for innovative approaches that not only address the symptoms but also promote healing and prevention of future injuries. Hydrogels are three-dimensional crosslinked networks of hydrophilic polymers that have gained significant attention in the field of biomedicine. Their unique properties, drug-delivery capabilities, and capacity to provide mechanical support make them promising tools in muscle damage management. Biomedical hydrogels hold significant potential as a preventive or alleviative approach for EIMD. This review provides a comprehensive overview of biomedical hydrogels as a promising approach for preventing and alleviating EIMD, addressing current challenges, and outlining future directions for research and development in the field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.